Scarica l'app Stockscreener
5.37
1.83%
-0.10
Precedente Chiudi:
$5.47
Aprire:
$5.5
Volume 24 ore:
12,945
Relative Volume:
0.35
Capitalizzazione di mercato:
$54.00M
Reddito:
$75.67M
Utile/perdita netta:
$-31.15M
Rapporto P/E:
-19.34
EPS:
-0.2777
Flusso di cassa netto:
$-39.79M
1 W Prestazione:
+1.13%
1M Prestazione:
-4.45%
6M Prestazione:
-60.44%
1 anno Prestazione:
-81.45%
Intervallo 1D:
$5.36
$5.53
Intervallo di 1 settimana:
$5.11
$5.61
Portata 52W:
$4.815
$31.50
Optinose Inc Stock (OPTN) Company Profile
Nome
Optinose Inc
Settore
Telefono
267-364-3500
Indirizzo
777 TOWNSHIP LINE ROAD, YARDLEY, PA
Confronta OPTN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OPTN
Optinose Inc
|
5.37 | 54.00M | 75.67M | -31.15M | -39.79M | -0.2777 |
|
ZTS
Zoetis Inc
|
160.06 | 71.67B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 47.44B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.19 | 46.08B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.46 | 18.86B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.36 | 13.97B | 612.78M | -86.37M | -62.91M | -0.87 |
Optinose Inc Stock (OPTN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-03 | Reiterato | H.C. Wainwright | Buy |
| 2024-03-11 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-21 | Iniziato | Lake Street | Buy |
| 2022-10-21 | Ripresa | Jefferies | Buy |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-12-18 | Iniziato | Cowen | Outperform |
| 2018-08-08 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Optinose Inc Borsa (OPTN) Ultime notizie
Optinose to Announce Q4 and Full-Year 2024 Financial Results on March 20, 2025 - MyChesCo
OptiNose (NASDAQ:OPTN) shareholders have endured a 90% loss from investing in the stock five years ago - Yahoo Finance
OptiNose (OPTN) Projected to Post Quarterly Earnings on Thursday - Defense World
Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
Optinose to Announce Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025 - Nasdaq
Optinose to Reveal Full Year Performance: Key Financial Results Coming March 20 - StockTitan
OptiNose, Inc. to Host Earnings Call - ACCESS Newswire
How the (OPTN) price action is used to our Advantage - Stock Traders Daily
Optinose CEO Mahmoud Ramy sells $33,729 in common stock By Investing.com - Investing.com South Africa
Optinose chief commercial officer sells $6,469 in stock - Investing.com India
Optinose chief commercial officer sells $6,469 in stock By Investing.com - Investing.com South Africa
Optinose CEO Mahmoud Ramy sells $33,729 in common stock - Investing.com
OptiNose Executives Sell Shares to Cover Tax Obligations - TradingView
Long Term Trading Analysis for (OPTN) - Stock Traders Daily
OptiNose, Inc. (NASDAQ:OPTN) Sees Significant Growth in Short Interest - MarketBeat
(OPTN) Technical Pivots with Risk Controls - Stock Traders Daily
OptiNose, Inc. (NASDAQ:OPTN) Sees Significant Decline in Short Interest - MarketBeat
Optinose Reports $22.4 Million in Preliminary Q4 Revenue for XHANCE - MSN
OptiNose (STU:0OP0) Inventories, Raw Materials & Components : €2.05 Mil (As of Sep. 2024) - GuruFocus.com
OptiNose (FRA:0OP0) Earnings per Share (Diluted) : €-3.84 (TTM As of Sep. 2024) - GuruFocus.com
Lake Street Capital Issues Pessimistic Forecast for OptiNose (NASDAQ:OPTN) Stock Price - Defense World
OptiNose (NASDAQ:OPTN) Price Target Cut to $17.00 by Analysts at Lake Street Capital - MarketBeat
OptiNose (FRA:0OP0) Short-Term Capital Lease Obligation : €0.91 Mil (As of Sep. 2024) - GuruFocus.com
Optinose price target adjusted for stock split at Lake Street - Yahoo Finance
Optinose reports preliminary Q4 2024 XHANCE revenue - MSN
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million - GlobeNewswire
OPTNOptiNose, Inc. Latest Stock News & Market Updates - StockTitan
Midday Market Movers: Biggest Stock Declines of the Day – Market - HPBL
Optinose Reports Strong Q4: XHANCE Revenue Hits $22.4M with 20% Prescription Growth - StockTitan
Windtree Announces the Addition of Leanne Kelly to Its Board of Directors - GlobeNewswire Inc.
OptiNose (STU:0OP0) Profitability Rank : 3 (As of Sep. 2024) - GuruFocus.com
OptiNose (STU:0OP0) Change In Inventory : €-3.06 Mil (TTM As of Sep. 2024) - GuruFocus.com
OptiNose, Inc. (NASDAQ:OPTN) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St
OptiNose (FRA:0OP0) Cyclically Adjusted Price-to-FCF : (As of Jan. 06, 2025) - GuruFocus.com
HC Wainwright Comments on OptiNose FY2029 Earnings - MarketBeat
HC Wainwright Forecasts OptiNose FY2029 Earnings - Defense World
Optinose price target adjusted for stock split at H.C. Wainwright - MSN
HC Wainwright Issues Positive Forecast for OptiNose (NASDAQ:OPTN) Stock Price - Defense World
Optinose stock price target raised at H.C. Wainwright given reverse split - Investing.com Canada
OptiNose (NASDAQ:OPTN) Shares Down 6.1%Time to Sell? - MarketBeat
OptiNose: Q1 Earnings Snapshot - Marketscreener.com
OptiNose, Inc. Announces Executive Appointments - Marketscreener.com
Optinose Announces Board Changes - Marketscreener.com
OptiNose stock hits 52-week high of $6.2 amid market fluctuations - Investing.com Nigeria
OptiNose stock hits 52-week high of $6.2 amid market fluctuations By Investing.com - Investing.com South Africa
Stock market news: Coeptis Therapeutics Holdings -96.03%, OptiNose -93.07% among biggest losers during mid day trading - Business Upturn
OptiNose (NASDAQ:OPTN) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Stock market today: Coeptis Therapeutics Holdings -95.79%, OptiNose -93.64% among biggest losers in early trading - Business Upturn
Optinose Inc Azioni (OPTN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.77%
0.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):